Mike Cintolo
Cabot Top Ten Trader
Geoffrey Seiler
Bullmarket.com
Sy Harding
Street Smart Report
Nicholas Vardy
Bull Market Alert

Veolia: The 'big fish' in water services


Bookmark and Share
by Nathan Slaughter, editor Scarcity & Wealth

Nathan SlaughterWhen it comes to water-related services, France's Veolia (VE) is the biggest fish in the ocean.

The company has operations on all seven continents and works with customers in nearly 70 countries, providing clean drinking water to more than 100 million customers.

Veolia is actively involved in the design and construction of water treatment facilities. Its seawater desalination plant in Bahrain is the biggest in the Middle East. And its Ashkelon reverse-osmosis facility in Israel is the largest of its kind in the world.

The company's strategy also includes partnering with local municipalities. This setup allows the company to hang on to its cash but still rake in heavy recurring revenues.

Veolia has formed these types of alliances all over the world, from Tampa to Shanghai to Paris (where the company oversees the city's 142 water districts).

But there is still plenty of upside in this under-penetrated market. According to Morningstar, just 10% of the U.S. water market is outsourced.

The remaining 90% is still handled directly by municipalities, most of which are deeply in debt and looking to shave red ink from the budget.


Handing over the reins to an experienced manager like Veolia can cut costs by up to 30% and save millions in annual expenses.

Even in a deteriorating global economy, every major city in the world still has to provide basic sanitation and water distribution on a daily basis.

And Veolia typically signs long-term concessions of up to 20 years, which makes for sticky revenue and predictable cash flow.

The company collects more than $50 billion in annual revenues, yet has a market value of just $8 billion. That gives the stock a microscopic price-to-sales ratio of 0.16.

A price-to-book ratio of 0.73 and a price/earnings-to-growth Ratio (PEG) of 0.5 tell the same story -- this is one sharply underpriced stock.

Once valued at more than $95 per share before the recession, VE sunk below $15 last week. Part of the problem is that utilities across the pond have struggled amid Europe's economic slump and budget woes.

But there are also company-specific concerns that have weighed on the stock, including lowered earnings guidance, large asset write-downs, and even accounting improprieties.

The bigger worry is the firm's hefty $20 billion net debt load, much of which comes due in the next few years and may have to be refinanced at higher rates.

These are all valid concerns that must be weighed carefully. But with a price in the mid-teens, these threats have been greatly over-exaggerated.

With the shares trading at half their $34 peak from just a few months ago, the potential triple-digit upside rewards more than outweigh the risks.

Veolia has been in business for more than 150 years. And the company isn't exactly foundering. In fact, it churned out $2.5 billion in operating cash flow during the first half of fiscal 2011.  

Much of that income is ladled out to shareholders. This past May, investors were treated to a distribution of $1.71 per share, for a lofty yield of 10.7%.

That level suggests the market is bracing for a dividend cut. I wouldn't rule out the possibility, but even if payments are halved, you can still lock in 5% payout at today's prices.

Action to Take --> I see no reason Veolia can't return to $30 within the next couple years and remain a global leader for decades thereafter.

Learn more about this financial newsletter at Nathan Slaughter's Scarcity & Wealth.

Advertisement
Banner
News Flash

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...


   

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 

Tesla: 'Out of the ball park'
by Timothy Lutts. editor Cabot Stock of the Month

Tesla (TSLA), our previously featured Stock of the Month and our top stock pick for 2013, knocked the ball out of the park in its latest quarter. The company exceeded analysts' expectations on all counts: cars sold, revenues, earnings, gross margins and more.


Read more...

 

5 ways to speculate on Cuba
by Jim Powell, editor Global Changes & Opportunities Report

With the death of Hugo Chavez in March, and Venezuela’s economic decline, the heavily subsidized oil lifeline is likely to be cut or sharply reduced. I think the resulting energy squeeze will force Cuba to allow greater foreign trade and investment.


Read more...

 

Big gains in nanotechnology?
by Doug Fabian, editor Making Money Alert

The nanotechnology niche focuses on very small, even microscopic, technology. Nanotech has produced technological developments in medicine (lasers), electronics (ink jet systems) and biomaterials (chemical and bio-detectors).


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary